Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.
about
Meningococcal VaccinationsReview of meningococcal vaccines with updates on immunization in adultsInfections of People with Complement Deficiencies and Patients Who Have Undergone SplenectomyUsing a scripted data entry process to transfer legacy immunization data while transitioning between electronic medical record systemsImpaired serotype-specific immune function following pneumococcal vaccination in infants with prior carriage.Meningococcal disease and the complement system.Meningococcal serogroup C conjugate vaccine.Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine.Extra-immunization as a clinical indicator for fragmentation of careMeningococcal disease: treatment and prevention.Immunologic hyporesponsiveness to serogroup C but not serogroup A following repeated meningococcal A/C polysaccharide vaccination in Saudi Arabia.Meningococcal conjugate vaccines: optimizing global impact.Serologic correlates of protection for evaluating the response to meningococcal vaccines.Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, andImmunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus.Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac.Practical review of immunizations in adult patients with cancer.Prospects for eradication of meningococcal diseaseExperience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135.No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccineExpanding prevention of invasive meningococcal disease.Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.
P2860
Q26752993-E2916CF6-40FE-480F-8A08-F651F63D6519Q28828692-A7BB776F-89ED-454D-8E3D-4252936FC12AQ28972389-4A3C82E8-5D9F-44A1-A011-93B721FD4B50Q30801425-2C1AC8D8-7784-406D-8961-423596A1D1E6Q33605125-8E8F3247-8143-48F2-AECA-29D2085E5255Q34376170-BD298E31-F6A5-4486-A5E4-BDB472BF92DEQ34482078-9984D28B-A425-49F1-BEE3-ABEDE9C2F210Q35013077-9454D6B9-D1B3-46F4-9DD4-A81AC30EB603Q35040464-646B4520-04A6-4544-9299-17BFF7F5FFF6Q35055030-34E9D740-806F-460D-9C3A-CA81CBB54D64Q35542416-187F1E94-CA63-4F75-98EE-CCB62794C5F8Q35547767-FBD45F27-4355-4B79-8C29-E9B2857DC3BEQ35648260-B6D2567F-B1A8-4CBA-8DB3-6B1229D04863Q36086273-8F277EB9-56A2-4B7B-B075-2FB858E0522BQ36210265-E046223A-E8FA-457A-A845-0C5EE4FF7A93Q36265075-546E73F3-CD16-414F-BFCD-B768F56F6FDDQ36388960-8C5818DC-B46F-49D4-9005-FEAF66C9B55AQ36440358-C630B197-C12F-4B6A-A76A-8E2CC6AFA915Q36600323-027C44AF-846D-4375-A5F3-C3EBC9C58144Q36984795-E303A5AC-645F-4909-82E2-C6BB444B6E79Q37503239-F8900812-9D93-40DD-A854-0757539CFC64Q37857246-1EAB3F2F-043D-4E99-903F-5CBB355FF51DQ54255446-6043C51E-5E5F-4B48-AC66-F206EAB732AE
P2860
Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@ast
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@en
type
label
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@ast
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@en
prefLabel
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@ast
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@en
P2093
P1433
P1476
Reduced antibody response to r ...... ysaccharide vaccine in adults.
@en
P2093
Kaczmarski E
Longworth E
P304
P356
10.1016/S0264-410X(00)00317-0
P407
P577
2000-12-01T00:00:00Z